Sun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: Report
- Sun Pharma plans a ₹10,000 crore bond sale to refinance its Organon deal
- The bonds are expected to mature in two, three and four years
- The refinancing affects Sun Pharma’s borrowing costs and balance sheet
